Midgard Science

Labs / CDMO: development & manufacturing

ADC Therapeutics

New Providence, NJ, United States · adctherapeutics.com

On your own

Free. Their own form.

Contact ADC Therapeutics directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

ADC Therapeutics is a biopharmaceutical company focused on antibody-drug conjugates for cancer. It develops and commercializes ZYNLONTA® for adults with certain types of relapsed or refractory large B-cell lymphoma and works from locations in New Providence, New Jersey and Epalinges, Switzerland.

Their website has a general contact form; we send your quote request through it.

What they offer

  • Develop antibody-drug conjugate therapeutics

    Develops ADC-based cancer therapies from its focused portfolio, including an FDA-approved anti-CD19 ADC.

  • Clinical development in hematologic cancers and solid tumors

    Seeks to expand ZYNLONTA® into earlier lines of diffuse large B-cell and indolent lymphomas and aims to address unmet medical needs in hematologic cancers and solid tumors.

What they work on

Modalities
Antibody, ADC, Cell therapy
Therapeutic areas
cancer, hematologic cancers, solid tumors, large B-cell lymphoma, diffuse large B-cell lymphoma, indolent lymphomas
Sites
Epalinges, Switzerland
Address
430 Mountain Avenue Suite #404 New Providence, NJ 07974, USA
Founded
2020

Similar labs. 3C Therapeutics, AGC Biologics, Bambusa Therapeutics, Intellective Bio

Found in a contract services directory. Listing built from adctherapeutics.com. Work here? Claim this listing.

ADC Therapeutics · Midgard Science